NCT06167187

Brief Summary

The aim of the study is to assess the efficacy of adding of pre-emptive inferior alveolar nerve block compared to the conventional systemic intravenous analgesia in controlling perioperative pain in fracture mandibular surgeries.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 2, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 12, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

December 12, 2023

Status Verified

December 1, 2023

Enrollment Period

10 months

First QC Date

December 2, 2023

Last Update Submit

December 9, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • The time of the first dose of fentanyl rescue analgesia intraoperative

    guided by hemodynamic changes

    Throughout the surgery

  • Total amount of additional intraoperative fentanyl rescue analgesia

    guided by hemodynamic changes

    Throughout the surgery

  • The time from recovery to the first dose pethidine rescue analgesic

    guided by visual analogue scale.

    24 hours postoperatively

  • Total amount of pethidine postoperative rescue analgesic

    guided by visual analogue scale.

    24 hours postoperatively

Secondary Outcomes (1)

  • Incidence of complications related to the block

    24 hours postoperatively

Study Arms (2)

Study group (IAN block group)

ACTIVE COMPARATOR

patients will receive bilateral inferior alveolar nerve block. 23 patients

Procedure: bilateral inferior alveolar nerve block

control group

ACTIVE COMPARATOR

patients will not receive the block and will receive intravenous multimodal analgesia according to standard protocol. 23 patients

Drug: Ketorolac and fentanyl

Interventions

Placing the tip of the thumb or forefinger into the coronoid notch (retromolar fossa) to help visualize the vertical height at which the needle will enter, and retracting the cheek to expose the pterygomandibular triangle. Placing the barrel of the syringe over the contralateral lower 1st and 2nd premolars and resting the side of the needle tip against the lateral edge of the pterygomandibular raphe, aiming the tip of the needle into the pterygomandibular triangle, with the bevel facing the ramus. Advancing the needle tip slightly into the mucosa until it is stopped by the ramus (typically after about 2 to 2.5 cm of insertion) and withdrawing needle 1 mm away from bone. Aspirating to rule out intravascular placement. If aspiration reveals intravascular placement, withdrawal of the needle will be done 2 to 3 mm, then reaspirating prior to injection. Slowly injecting about 2 to 4 milliliters of bupivacaine 0.5% anesthetic in each side..

Also known as: IANB
Study group (IAN block group)

in control group, Patients will not receive the block and pain will be controlled according to institutional protocol using 30 mg ketorolac IV and fentanyl increments as needed.

control group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age group: 18 - 65 years old.
  • American Society of Anesthesiologists (ASA) Physical Status Class I to III
  • Scheduled for fracture mandible fixation.

You may not qualify if:

  • Refusing to participate in the study.
  • History of allergy to the medications used in the study.
  • Contraindications to regional anesthesia (including coagulopathy and local infection).
  • Psychiatric disorders.
  • Pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of medicine - Ain shams university hospitals

Cairo, 11591, Egypt

RECRUITING

MeSH Terms

Interventions

KetorolacFentanyl

Intervention Hierarchy (Ancestors)

IndomethacinIndolesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsPiperidinesHeterocyclic Compounds, 1-Ring

Study Officials

  • Mohamed Atef, ass.lecturer

    faculty of medicine, ain shams university

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mohamed Atef, ass.lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecturer of anesthesia

Study Record Dates

First Submitted

December 2, 2023

First Posted

December 12, 2023

Study Start

June 1, 2023

Primary Completion

April 1, 2024

Study Completion

June 1, 2024

Last Updated

December 12, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations